DC preparations for therapy.
This review describes and compares the different DC preparations currently under laboratory and clinical investigation as vehicles for cancer immunotherapy.
Rice
A M
AM
Cancer Biotherapy Laboratory, Mater Medical Research Institute, South Brisbane, QD, Australia.
Jones
K L
KL
Hart
D N J
DN
D015703:Antigens, CD / Q000276:immunology; D018929:Cell Culture Techniques / Q000379:methods; D002454:Cell Differentiation / Q000187:drug effects / Q000276:immunology; D002455:Cell Division / Q000276:immunology; D002469:Cell Separation; D002478:Cells, Cultured; D016207:Cytokines / Q000276:immunology / Q000494:pharmacology; D003713:Dendritic Cells / Q000276:immunology* / Q000637:transplantation; D006412:Hematopoietic Stem Cells / Q000276:immunology*; D006801:Humans; D007116:Immunization, Passive; D007167:Immunotherapy; D008213:Lymphocyte Activation / Q000276:immunology; D009000:Monocytes / Q000276:immunology*; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology; D014612:Vaccines
D015703:Antigens, CD; D016207:Cytokines; D014612:Vaccines